Comparative Efficacy, Tolerability, and Acceptability of Donanemab, Lecanemab, Aducanumab, Melatonin, and Aerobic Exercise for a Short Time on Cognitive Function in Mild Cognitive Impairment and Mild Alzheimer's Disease Terao I, Kodama W J Alzheimers Dis. 2024; 98(3):825-835. PMID: 38461503. Abstract Comment | 1 comment Bookmark Recommend Follow Comment | Bookmark | Recommend | Follow Comments This is an excellent work. This is an excellent work. Log in or register to post comments
- Comment
|